Clinical Trial Update: Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial compares capecitabine plus bevacizumab with radiotherapy to capecitabine with radiotherapy as neoadjuvant treatment for localized, resectable…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED